New Insights into the Cell- and Tissue-specificity of Glucocorticoid Actions

Overview

Journal Cell Mol Immunol

Date 2020 Sep 2

PMID 32868909

Citations 58

Authors

Linda Quatrini

Sophie Ugolini

Affiliations

Soon will be listed here.

Abstract

Glucocorticoids (GCs) are endogenous hormones that are crucial for the homeostasis of the organism and adaptation to the external environment. Because of their anti-inflammatory effects, synthetic GCs are also extensively used in clinical practice. However, almost all cells in the body are sensitive to GC regulation. As a result, these mediators have pleiotropic effects, which may be undesirable or detrimental to human health. Here, we summarize the recent findings that contribute to deciphering the molecular mechanisms downstream of glucocorticoid receptor activation. We also discuss the complex role of GCs in infectious diseases such as sepsis and COVID-19, in which the balance between pathogen elimination and protection against excessive inflammation and immunopathology needs to be tightly regulated. An understanding of the cell type- and context-specific actions of GCs from the molecular to the organismal level would help to optimize their therapeutic use.

Citing Articles

A high-throughput platform for single-molecule tracking identifies drug interaction and cellular mechanisms.

McSwiggen D, Liu H, Tan R, Agramunt Puig S, Akella L, Berman R Elife. 2025; 12.

PMID: 39786807 PMC: 11717362. DOI: 10.7554/eLife.93183.

Connecting dots of long COVID-19 pathogenesis: a vagus nerve- hypothalamic-pituitary- adrenal-mitochondrial axis dysfunction.

Camici M, Del Duca G, Brita A, Antinori A Front Cell Infect Microbiol. 2024; 14:1501949.

PMID: 39735263 PMC: 11671747. DOI: 10.3389/fcimb.2024.1501949.

Oxidative Stress and Antioxidants in Pediatric Asthma's Evolution and Management.

Ioniuc I, Lupu A, Dragan F, Tarnita I, Alexoae M, Streanga V Antioxidants (Basel). 2024; 13(11).

PMID: 39594473 PMC: 11590961. DOI: 10.3390/antiox13111331.

PU.1 eviction at lymphocyte-specific chromatin domains mediates glucocorticoid response in acute lymphoblastic leukemia.

Beck D, Cao H, Tian F, Huang Y, Jiang M, Zhao H Nat Commun. 2024; 15(1):9697.

PMID: 39516193 PMC: 11549222. DOI: 10.1038/s41467-024-54096-2.

Association of cumulative methylprednisolone dosages with mortality risk from pneumonia in connective tissue disease patients.

Wang S, Ye Q Sci Rep. 2024; 14(1):26502.

PMID: 39489823 PMC: 11532547. DOI: 10.1038/s41598-024-78233-5.

References

Oster H, Challet E, Ott V, Arvat E, de Kloet E, Dijk D . The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids. Endocr Rev. 2016; 38(1):3-45. PMC: 5563520. DOI: 10.1210/er.2015-1080. View

Cole T, Blendy J, Monaghan A, Krieglstein K, Schmid W, Aguzzi A . Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 1995; 9(13):1608-21. DOI: 10.1101/gad.9.13.1608. View

Vandewalle J, Luypaert A, De Bosscher K, Libert C . Therapeutic Mechanisms of Glucocorticoids. Trends Endocrinol Metab. 2017; 29(1):42-54. DOI: 10.1016/j.tem.2017.10.010. View

Frei 3rd E, Karon M, LEVIN R, Freireich E, Taylor R, HANANIAN J . The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. Blood. 1965; 26(5):642-56. View

Herr I, Pfitzenmaier J . Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases. Lancet Oncol. 2006; 7(5):425-30. DOI: 10.1016/S1470-2045(06)70694-5. View

Holgate S, Polosa R . Treatment strategies for allergy and asthma. Nat Rev Immunol. 2008; 8(3):218-30. DOI: 10.1038/nri2262. View

Dendoncker K, Libert C . Glucocorticoid resistance as a major drive in sepsis pathology. Cytokine Growth Factor Rev. 2017; 35:85-96. DOI: 10.1016/j.cytogfr.2017.04.002. View

Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M . Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 2002; 16(1):61-71. DOI: 10.1096/fj.01-0245com. View

Cain D, Cidlowski J . Immune regulation by glucocorticoids. Nat Rev Immunol. 2017; 17(4):233-247. PMC: 9761406. DOI: 10.1038/nri.2017.1. View

10.

Kadmiel M, Cidlowski J . Glucocorticoid receptor signaling in health and disease. Trends Pharmacol Sci. 2013; 34(9):518-30. PMC: 3951203. DOI: 10.1016/j.tips.2013.07.003. View

11.

Meijsing S, Pufall M, So A, Bates D, Chen L, Yamamoto K . DNA binding site sequence directs glucocorticoid receptor structure and activity. Science. 2009; 324(5925):407-10. PMC: 2777810. DOI: 10.1126/science.1164265. View

12.

Hudson W, Youn C, Ortlund E . The structural basis of direct glucocorticoid-mediated transrepression. Nat Struct Mol Biol. 2012; 20(1):53-8. PMC: 3539207. DOI: 10.1038/nsmb.2456. View

13.

Timmermans S, Souffriau J, Libert C . A General Introduction to Glucocorticoid Biology. Front Immunol. 2019; 10:1545. PMC: 6621919. DOI: 10.3389/fimmu.2019.01545. View

14.

Rhen T, Cidlowski J . Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N Engl J Med. 2005; 353(16):1711-23. DOI: 10.1056/NEJMra050541. View

15.

Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, Cato A . Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 2001; 20(24):7108-16. PMC: 125780. DOI: 10.1093/emboj/20.24.7108. View

16.

Lasa M, Abraham S, Boucheron C, Saklatvala J, Clark A . Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol. 2002; 22(22):7802-11. PMC: 134716. DOI: 10.1128/MCB.22.22.7802-7811.2002. View

17.

De Bosscher K, Vanden Berghe W, Vermeulen L, Plaisance S, Boone E, Haegeman G . Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Natl Acad Sci U S A. 2000; 97(8):3919-24. PMC: 18117. DOI: 10.1073/pnas.97.8.3919. View

18.

De Bosscher K, Vanden Berghe W, Haegeman G . The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev. 2003; 24(4):488-522. DOI: 10.1210/er.2002-0006. View

19.

Berrebi D, Bruscoli S, Cohen N, Foussat A, Migliorati G, Bouchet-Delbos L . Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood. 2002; 101(2):729-38. DOI: 10.1182/blood-2002-02-0538. View

20.

Oakley R, Cidlowski J . Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J Biol Chem. 2010; 286(5):3177-84. PMC: 3030321. DOI: 10.1074/jbc.R110.179325. View